Europeptides Part of Tides Europe, Berlin

Where peptide leaders meet to build successful partnerships and accelerate products across all development phases

Increase half-life and minimise manufacturing costs through new data, case studies and technologies for peptide therapeutics

Lead optimisation strategies to improve drug-like properties for next generation peptide therapeutics

- Peptide therapeutics beyond metabolic diseases
Where are the future opportunities?
- Overcome the challenges of translating early leads into the clinic - Zealand Pharma and Amgen provide successful lead optimisation and engineering insights
- New frontiers in peptide design– What are the latest developments in peptide vaccines, conjugates, macrocyclic and antimicrobial peptides?
- Increasing the half-life, targeting and stability of peptide products – What are the cutting edge methodologies to move to longer exposure times?

New techniques for improved administration of peptide products

- Preclinical and clinical developments of complex peptides – What are the most exciting products advancing through the clinic?
- Benchmark your clinical programmes with case studies insights from Bicycle Therapeutics and Polyphor
- Non-invasive delivery methods - What are the latest advances in orally bioavailable, transdermal and controlled release peptides?
- Formulation strategies – Which are the winning techniques and technologies for sustained release?

Price:
2 Day Conference Pass (Days 2 and 3): GBP 1349

Speakers: Marie Skovgaard, Elisabetta Bianchi, Joel Richard, Thomas Vorherr, Bradley Pentelute, Thomas Meier

Category: Conferences | Science, Health and Medicine